| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogen Peroxide | 26 | 2024 | 732 | 6.960 |
Why?
|
| Nitric Oxide Synthase Type III | 49 | 2024 | 704 | 5.710 |
Why?
|
| Nitric Oxide Synthase | 68 | 2019 | 908 | 5.090 |
Why?
|
| Endothelium, Vascular | 66 | 2022 | 4437 | 3.770 |
Why?
|
| Nitric Oxide | 41 | 2024 | 2141 | 3.280 |
Why?
|
| Oxidative Stress | 17 | 2024 | 3107 | 2.500 |
Why?
|
| rac1 GTP-Binding Protein | 8 | 2024 | 242 | 2.400 |
Why?
|
| Endothelial Cells | 20 | 2022 | 3537 | 2.230 |
Why?
|
| Lysophospholipids | 12 | 2013 | 339 | 2.020 |
Why?
|
| Caveolins | 14 | 2010 | 102 | 2.020 |
Why?
|
| Sphingosine | 11 | 2013 | 308 | 1.890 |
Why?
|
| Myocytes, Cardiac | 9 | 2022 | 1656 | 1.860 |
Why?
|
| Signal Transduction | 45 | 2024 | 23363 | 1.730 |
Why?
|
| Cattle | 46 | 2014 | 3847 | 1.700 |
Why?
|
| Oxidation-Reduction | 13 | 2024 | 2222 | 1.610 |
Why?
|
| Amino Acid Oxidoreductases | 19 | 1995 | 149 | 1.510 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 2022 | 819 | 1.420 |
Why?
|
| Enzyme Activation | 28 | 2019 | 3604 | 1.390 |
Why?
|
| AMP-Activated Protein Kinases | 7 | 2020 | 600 | 1.180 |
Why?
|
| Phosphorylation | 38 | 2024 | 8314 | 1.160 |
Why?
|
| Adenosine Diphosphate | 4 | 2014 | 429 | 1.140 |
Why?
|
| Nitroglycerin | 3 | 2015 | 329 | 1.040 |
Why?
|
| Reactive Oxygen Species | 7 | 2024 | 2138 | 0.920 |
Why?
|
| Aorta | 16 | 2015 | 2042 | 0.860 |
Why?
|
| Calmodulin | 8 | 2010 | 217 | 0.860 |
Why?
|
| Caveolin 1 | 13 | 2014 | 257 | 0.860 |
Why?
|
| Friedreich Ataxia | 1 | 2023 | 77 | 0.830 |
Why?
|
| Vasodilator Agents | 3 | 2015 | 977 | 0.800 |
Why?
|
| Membrane Proteins | 18 | 2016 | 7854 | 0.780 |
Why?
|
| Simvastatin | 3 | 2022 | 352 | 0.770 |
Why?
|
| Cells, Cultured | 51 | 2021 | 18968 | 0.770 |
Why?
|
| Animals | 124 | 2024 | 167940 | 0.740 |
Why?
|
| RNA, Small Interfering | 13 | 2014 | 3443 | 0.730 |
Why?
|
| Heart Failure | 5 | 2024 | 11835 | 0.720 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2023 | 2874 | 0.710 |
Why?
|
| Caveolae | 3 | 2012 | 55 | 0.690 |
Why?
|
| Gene Expression Regulation, Enzymologic | 6 | 2012 | 1173 | 0.680 |
Why?
|
| D-Amino-Acid Oxidase | 1 | 2019 | 26 | 0.680 |
Why?
|
| Molecular Imaging | 2 | 2019 | 817 | 0.670 |
Why?
|
| Oxidants | 4 | 2021 | 169 | 0.660 |
Why?
|
| Receptors, Cell Surface | 9 | 2005 | 2825 | 0.650 |
Why?
|
| Biosensing Techniques | 4 | 2019 | 679 | 0.620 |
Why?
|
| Amino Acids | 5 | 2024 | 1715 | 0.580 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2019 | 435 | 0.540 |
Why?
|
| Receptors, Bradykinin | 3 | 2001 | 19 | 0.540 |
Why?
|
| Nitric Oxide Synthase Type I | 3 | 2011 | 174 | 0.540 |
Why?
|
| Disease Models, Animal | 12 | 2024 | 18134 | 0.520 |
Why?
|
| Protease Inhibitors | 1 | 2019 | 755 | 0.510 |
Why?
|
| Insulin | 7 | 2017 | 6592 | 0.510 |
Why?
|
| Immunoblotting | 10 | 2014 | 1649 | 0.510 |
Why?
|
| Vasoconstriction | 2 | 2009 | 592 | 0.500 |
Why?
|
| Myocardial Contraction | 9 | 2011 | 1516 | 0.500 |
Why?
|
| Transfection | 21 | 2009 | 5782 | 0.490 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 3 | 2016 | 124 | 0.490 |
Why?
|
| Fungal Proteins | 1 | 2019 | 911 | 0.490 |
Why?
|
| Immediate-Early Proteins | 3 | 2003 | 449 | 0.480 |
Why?
|
| Cardiomegaly | 3 | 2023 | 593 | 0.480 |
Why?
|
| Myocardium | 13 | 2012 | 4688 | 0.470 |
Why?
|
| Protein Processing, Post-Translational | 10 | 2016 | 1977 | 0.470 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2003 | 1244 | 0.460 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2014 | 42 | 0.460 |
Why?
|
| Proto-Oncogene Proteins c-akt | 9 | 2017 | 2449 | 0.460 |
Why?
|
| Arginine | 6 | 2013 | 934 | 0.460 |
Why?
|
| Homoarginine | 1 | 2013 | 9 | 0.460 |
Why?
|
| Amidinotransferases | 1 | 2013 | 11 | 0.450 |
Why?
|
| Cell Movement | 9 | 2024 | 5206 | 0.450 |
Why?
|
| Bradykinin | 5 | 2001 | 208 | 0.450 |
Why?
|
| Palmitic Acid | 6 | 2002 | 149 | 0.450 |
Why?
|
| Calcium | 9 | 2019 | 5726 | 0.450 |
Why?
|
| Tetrazoles | 1 | 2019 | 901 | 0.440 |
Why?
|
| Angiotensin II | 3 | 2015 | 850 | 0.430 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3333 | 0.430 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 2 | 2009 | 30 | 0.420 |
Why?
|
| Endothelial Growth Factors | 3 | 2003 | 674 | 0.390 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2012 | 162 | 0.390 |
Why?
|
| Lymphokines | 3 | 2003 | 929 | 0.380 |
Why?
|
| Phosphatidylinositol 3-Kinases | 6 | 2009 | 2866 | 0.370 |
Why?
|
| Gene Knockdown Techniques | 4 | 2024 | 1617 | 0.370 |
Why?
|
| Nitric Oxide Synthase Type II | 5 | 2007 | 514 | 0.350 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2014 | 496 | 0.350 |
Why?
|
| Mice | 35 | 2024 | 81216 | 0.340 |
Why?
|
| Epinephrine | 9 | 2007 | 791 | 0.340 |
Why?
|
| COS Cells | 10 | 2003 | 1129 | 0.330 |
Why?
|
| Vascular Endothelial Growth Factor A | 10 | 2022 | 3483 | 0.330 |
Why?
|
| Sulfhydryl Compounds | 2 | 2009 | 299 | 0.330 |
Why?
|
| GTP Cyclohydrolase | 1 | 2009 | 47 | 0.330 |
Why?
|
| Capillary Permeability | 1 | 2012 | 768 | 0.320 |
Why?
|
| Nucleotides, Cyclic | 1 | 2009 | 84 | 0.320 |
Why?
|
| Mutagenesis, Site-Directed | 6 | 2005 | 1694 | 0.320 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2009 | 133 | 0.320 |
Why?
|
| Acylation | 8 | 2010 | 98 | 0.320 |
Why?
|
| Myristic Acids | 7 | 1998 | 49 | 0.310 |
Why?
|
| Thiolester Hydrolases | 3 | 2013 | 85 | 0.300 |
Why?
|
| Cell Compartmentation | 6 | 1998 | 385 | 0.300 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2004 | 1246 | 0.300 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2007 | 62 | 0.300 |
Why?
|
| Enzyme Inhibitors | 8 | 2009 | 3726 | 0.290 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 1115 | 0.290 |
Why?
|
| Microfilament Proteins | 2 | 2009 | 1134 | 0.290 |
Why?
|
| Metabolome | 1 | 2014 | 976 | 0.280 |
Why?
|
| Recombinant Proteins | 12 | 2006 | 6543 | 0.280 |
Why?
|
| Neuropeptides | 1 | 2012 | 941 | 0.270 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2016 | 1484 | 0.270 |
Why?
|
| Cell Adhesion Molecules | 2 | 2009 | 1602 | 0.270 |
Why?
|
| Vasodilation | 3 | 2015 | 964 | 0.270 |
Why?
|
| Muscle Tonus | 2 | 2003 | 82 | 0.270 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2006 | 94 | 0.260 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2005 | 544 | 0.260 |
Why?
|
| Phosphoproteins | 3 | 2009 | 2441 | 0.260 |
Why?
|
| Autophagy | 1 | 2014 | 1336 | 0.260 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2008 | 436 | 0.260 |
Why?
|
| Down-Regulation | 4 | 2020 | 2918 | 0.260 |
Why?
|
| Dependovirus | 2 | 2022 | 708 | 0.250 |
Why?
|
| Cyclic GMP | 7 | 2009 | 395 | 0.250 |
Why?
|
| Rats, Wistar | 2 | 2019 | 1849 | 0.250 |
Why?
|
| Protein Isoforms | 3 | 2022 | 1697 | 0.240 |
Why?
|
| Myristic Acid | 7 | 2002 | 49 | 0.240 |
Why?
|
| Mice, Knockout | 13 | 2016 | 14396 | 0.240 |
Why?
|
| Nitrogen | 1 | 2005 | 350 | 0.230 |
Why?
|
| Palmitic Acids | 4 | 1998 | 52 | 0.230 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2011 | 10829 | 0.230 |
Why?
|
| Receptors, Adrenergic, beta | 7 | 2009 | 241 | 0.230 |
Why?
|
| Isoenzymes | 7 | 2006 | 1690 | 0.220 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 666 | 0.220 |
Why?
|
| Calcium Signaling | 2 | 2007 | 731 | 0.220 |
Why?
|
| Receptors, Adrenergic | 8 | 1992 | 155 | 0.220 |
Why?
|
| Receptor Cross-Talk | 1 | 2003 | 116 | 0.220 |
Why?
|
| Receptors, Growth Factor | 2 | 2003 | 326 | 0.220 |
Why?
|
| Catalase | 2 | 2014 | 216 | 0.210 |
Why?
|
| Molecular Sequence Data | 19 | 2016 | 17628 | 0.210 |
Why?
|
| Cyclosporine | 2 | 2002 | 778 | 0.210 |
Why?
|
| Androstadienes | 4 | 2007 | 348 | 0.200 |
Why?
|
| Adrenergic beta-Agonists | 5 | 2011 | 345 | 0.200 |
Why?
|
| Endothelium | 3 | 2008 | 764 | 0.200 |
Why?
|
| Heart Ventricles | 6 | 2013 | 3811 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2005 | 558 | 0.200 |
Why?
|
| Animals, Newborn | 3 | 2024 | 2671 | 0.200 |
Why?
|
| Glutathione | 3 | 2019 | 582 | 0.200 |
Why?
|
| Cell Line | 14 | 2014 | 15626 | 0.200 |
Why?
|
| Receptors, Adrenergic, alpha | 7 | 1984 | 146 | 0.200 |
Why?
|
| Rats | 20 | 2022 | 23695 | 0.200 |
Why?
|
| Base Sequence | 14 | 2005 | 12447 | 0.190 |
Why?
|
| Heart | 4 | 2010 | 4392 | 0.190 |
Why?
|
| Serine | 5 | 2009 | 831 | 0.190 |
Why?
|
| Cytosol | 3 | 2019 | 887 | 0.190 |
Why?
|
| Physical Therapy Modalities | 3 | 1995 | 536 | 0.190 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2002 | 330 | 0.190 |
Why?
|
| Biological Phenomena | 1 | 2021 | 28 | 0.190 |
Why?
|
| Histamine | 1 | 2022 | 499 | 0.180 |
Why?
|
| Ataxia | 1 | 2023 | 305 | 0.180 |
Why?
|
| Bone Marrow Cells | 2 | 2008 | 2424 | 0.180 |
Why?
|
| Isoproterenol | 6 | 2011 | 394 | 0.180 |
Why?
|
| Cloning, Molecular | 7 | 1998 | 4172 | 0.180 |
Why?
|
| Humans | 71 | 2024 | 760261 | 0.180 |
Why?
|
| Alanine | 2 | 2022 | 607 | 0.180 |
Why?
|
| Angina Pectoris | 2 | 2015 | 969 | 0.170 |
Why?
|
| Receptors, Lysosphingolipid | 3 | 2013 | 121 | 0.170 |
Why?
|
| Palmitoyl-CoA Hydrolase | 1 | 1999 | 17 | 0.170 |
Why?
|
| Spodoptera | 4 | 2006 | 141 | 0.170 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2018 | 3735 | 0.170 |
Why?
|
| Kinetics | 12 | 2009 | 6378 | 0.170 |
Why?
|
| Cyclic AMP | 5 | 2011 | 1455 | 0.170 |
Why?
|
| Amino Acid Sequence | 15 | 2016 | 13456 | 0.160 |
Why?
|
| Precipitin Tests | 4 | 2002 | 815 | 0.160 |
Why?
|
| Anaphylaxis | 1 | 2006 | 753 | 0.160 |
Why?
|
| Carbachol | 4 | 1998 | 223 | 0.160 |
Why?
|
| Heart Rate | 4 | 2009 | 4169 | 0.160 |
Why?
|
| Microscopy, Fluorescence | 4 | 2014 | 2651 | 0.160 |
Why?
|
| Hypoglycemic Agents | 2 | 2010 | 3149 | 0.160 |
Why?
|
| Ceramides | 1 | 1999 | 200 | 0.150 |
Why?
|
| Stereotyping | 1 | 2000 | 239 | 0.150 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2011 | 482 | 0.150 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 361 | 0.150 |
Why?
|
| Sirtuins | 1 | 2021 | 320 | 0.150 |
Why?
|
| Receptors, Lysophospholipid | 3 | 2003 | 40 | 0.150 |
Why?
|
| Mitochondria, Heart | 1 | 2019 | 229 | 0.150 |
Why?
|
| DNA, Complementary | 4 | 2005 | 1993 | 0.150 |
Why?
|
| Protein Binding | 8 | 2007 | 9336 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2019 | 5640 | 0.150 |
Why?
|
| Occupations | 1 | 2000 | 515 | 0.150 |
Why?
|
| Blood Platelets | 9 | 2016 | 2522 | 0.150 |
Why?
|
| Sequence Deletion | 3 | 1998 | 1493 | 0.150 |
Why?
|
| Fluorescent Dyes | 4 | 2013 | 1914 | 0.150 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2017 | 2058 | 0.140 |
Why?
|
| Genetic Vectors | 3 | 2019 | 3378 | 0.140 |
Why?
|
| Injections, Intravenous | 1 | 2019 | 1388 | 0.140 |
Why?
|
| Muscle Relaxation | 2 | 2010 | 138 | 0.140 |
Why?
|
| HEK293 Cells | 4 | 2015 | 4264 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 2003 | 749 | 0.140 |
Why?
|
| Neprilysin | 1 | 2019 | 472 | 0.140 |
Why?
|
| Diabetic Angiopathies | 1 | 2001 | 822 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1655 | 0.130 |
Why?
|
| Alexander Disease | 1 | 2015 | 15 | 0.130 |
Why?
|
| GTP-Binding Proteins | 6 | 1999 | 951 | 0.130 |
Why?
|
| Proteins | 2 | 2009 | 6030 | 0.130 |
Why?
|
| Teaching Rounds | 1 | 2020 | 275 | 0.130 |
Why?
|
| Mice, Transgenic | 5 | 2023 | 9531 | 0.130 |
Why?
|
| Microscopy, Confocal | 3 | 2015 | 1972 | 0.130 |
Why?
|
| Renin-Angiotensin System | 1 | 2020 | 739 | 0.130 |
Why?
|
| Actin-Related Protein 2-3 Complex | 2 | 2016 | 60 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 4 | 2019 | 5784 | 0.120 |
Why?
|
| Baculoviridae | 1 | 1995 | 115 | 0.120 |
Why?
|
| Diabetes Mellitus | 2 | 2014 | 5884 | 0.120 |
Why?
|
| History, 18th Century | 1 | 2015 | 207 | 0.120 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2015 | 94 | 0.120 |
Why?
|
| RNA, Transfer, Amino Acyl | 1 | 2014 | 46 | 0.120 |
Why?
|
| Biphenyl Compounds | 1 | 2019 | 988 | 0.120 |
Why?
|
| Cell-Derived Microparticles | 1 | 2016 | 161 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2001 | 4494 | 0.120 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2014 | 41 | 0.120 |
Why?
|
| Troponin T | 1 | 2019 | 774 | 0.120 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 305 | 0.120 |
Why?
|
| Thrombopoiesis | 1 | 2016 | 164 | 0.120 |
Why?
|
| Plasmids | 3 | 2005 | 2277 | 0.110 |
Why?
|
| Cell Membrane | 10 | 2000 | 3683 | 0.110 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2015 | 550 | 0.110 |
Why?
|
| Energy Metabolism | 2 | 2019 | 2869 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 1994 | 311 | 0.110 |
Why?
|
| Biological Transport | 6 | 1999 | 2087 | 0.110 |
Why?
|
| Cartilage, Articular | 1 | 2021 | 1091 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2005 | 474 | 0.110 |
Why?
|
| Interleukin-1 | 3 | 2004 | 1250 | 0.110 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 1025 | 0.110 |
Why?
|
| Autonomic Nervous System | 1 | 1998 | 697 | 0.110 |
Why?
|
| DNA Primers | 5 | 2004 | 2819 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2005 | 478 | 0.110 |
Why?
|
| Drug Combinations | 1 | 2019 | 2024 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 12281 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 3 | 2013 | 1335 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1521 | 0.110 |
Why?
|
| Multigene Family | 2 | 1997 | 1079 | 0.110 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2014 | 419 | 0.110 |
Why?
|
| Transcription, Genetic | 5 | 2018 | 7593 | 0.110 |
Why?
|
| Pyloric Stenosis | 1 | 1992 | 28 | 0.110 |
Why?
|
| Homeostasis | 4 | 2021 | 3305 | 0.110 |
Why?
|
| Glutathione Peroxidase | 1 | 2014 | 256 | 0.110 |
Why?
|
| History, 19th Century | 1 | 2015 | 720 | 0.110 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2013 | 88 | 0.100 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2013 | 202 | 0.100 |
Why?
|
| Fatty Acids | 3 | 2008 | 1805 | 0.100 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2009 | 1256 | 0.100 |
Why?
|
| Methionine | 1 | 2015 | 569 | 0.100 |
Why?
|
| Methylene Blue | 1 | 1993 | 157 | 0.100 |
Why?
|
| Receptors, Muscarinic | 3 | 1998 | 157 | 0.100 |
Why?
|
| Nifedipine | 1 | 2012 | 221 | 0.100 |
Why?
|
| Actins | 2 | 2013 | 2049 | 0.100 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 1993 | 239 | 0.100 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 685 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2012 | 140 | 0.100 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 1259 | 0.100 |
Why?
|
| Subcellular Fractions | 3 | 2004 | 532 | 0.100 |
Why?
|
| Stroke | 2 | 2013 | 9945 | 0.100 |
Why?
|
| Enzyme Stability | 1 | 2011 | 220 | 0.100 |
Why?
|
| Megakaryocytes | 1 | 2016 | 566 | 0.100 |
Why?
|
| Hypertension | 3 | 2020 | 8595 | 0.090 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2011 | 102 | 0.090 |
Why?
|
| Methyltransferases | 1 | 2014 | 373 | 0.090 |
Why?
|
| Antioxidants | 1 | 2019 | 1668 | 0.090 |
Why?
|
| Calcium Channels, L-Type | 1 | 2012 | 240 | 0.090 |
Why?
|
| Lipase | 1 | 2013 | 324 | 0.090 |
Why?
|
| Time Factors | 7 | 2010 | 40133 | 0.090 |
Why?
|
| Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2010 | 86 | 0.090 |
Why?
|
| Guanylate Cyclase | 3 | 2009 | 205 | 0.090 |
Why?
|
| RNA, Messenger | 6 | 2005 | 12762 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2010 | 4127 | 0.090 |
Why?
|
| Blood Vessels | 1 | 2016 | 1112 | 0.090 |
Why?
|
| Nitrosation | 2 | 2007 | 25 | 0.090 |
Why?
|
| Proteomics | 1 | 2024 | 3810 | 0.090 |
Why?
|
| Glutathione Reductase | 1 | 2009 | 24 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 688 | 0.090 |
Why?
|
| Receptor, Bradykinin B2 | 2 | 2000 | 24 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 830 | 0.090 |
Why?
|
| Phosphorus Radioisotopes | 2 | 2002 | 100 | 0.090 |
Why?
|
| Thioredoxin Reductase 2 | 1 | 2009 | 25 | 0.090 |
Why?
|
| Casein Kinase II | 2 | 2016 | 122 | 0.090 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2009 | 32 | 0.090 |
Why?
|
| Naphthalimides | 1 | 2009 | 22 | 0.090 |
Why?
|
| Interferon-gamma | 3 | 1995 | 3160 | 0.090 |
Why?
|
| Genes | 1 | 1994 | 1845 | 0.090 |
Why?
|
| Saphenous Vein | 3 | 2003 | 538 | 0.090 |
Why?
|
| Lentivirus | 1 | 2013 | 505 | 0.090 |
Why?
|
| Thionucleotides | 1 | 2009 | 112 | 0.080 |
Why?
|
| Consensus Sequence | 3 | 1996 | 367 | 0.080 |
Why?
|
| Electrochemistry | 1 | 2009 | 143 | 0.080 |
Why?
|
| Enzyme Activators | 1 | 2009 | 57 | 0.080 |
Why?
|
| Electric Impedance | 1 | 2014 | 751 | 0.080 |
Why?
|
| Cell Size | 1 | 2011 | 623 | 0.080 |
Why?
|
| Streptokinase | 1 | 1989 | 187 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 2473 | 0.080 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1992 | 305 | 0.080 |
Why?
|
| Heart Failure, Diastolic | 1 | 2010 | 77 | 0.080 |
Why?
|
| Calcium Channel Blockers | 1 | 2012 | 694 | 0.080 |
Why?
|
| Amino Acid Substitution | 2 | 2005 | 1737 | 0.080 |
Why?
|
| Terpenes | 1 | 2009 | 96 | 0.080 |
Why?
|
| Copper | 1 | 2011 | 368 | 0.080 |
Why?
|
| Cardiovascular Diseases | 2 | 2012 | 15740 | 0.080 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2009 | 173 | 0.080 |
Why?
|
| Lipoproteins, HDL | 1 | 2013 | 667 | 0.080 |
Why?
|
| Aldehyde-Lyases | 1 | 2008 | 13 | 0.080 |
Why?
|
| Phenylhydrazines | 1 | 2008 | 28 | 0.080 |
Why?
|
| History, 20th Century | 2 | 2015 | 2777 | 0.080 |
Why?
|
| Liver | 5 | 2016 | 7512 | 0.080 |
Why?
|
| Blotting, Northern | 3 | 2003 | 1544 | 0.080 |
Why?
|
| Guanylyl Imidodiphosphate | 5 | 1984 | 37 | 0.080 |
Why?
|
| Adrenergic beta-3 Receptor Antagonists | 1 | 2007 | 1 | 0.080 |
Why?
|
| Molecular Mimicry | 1 | 2009 | 200 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 7 | 2004 | 6067 | 0.080 |
Why?
|
| Pertussis Toxin | 3 | 2005 | 176 | 0.080 |
Why?
|
| Astrocytes | 1 | 2015 | 1335 | 0.070 |
Why?
|
| Vasoconstrictor Agents | 1 | 2011 | 651 | 0.070 |
Why?
|
| Vascular Diseases | 1 | 2016 | 1180 | 0.070 |
Why?
|
| Models, Biological | 5 | 2013 | 9468 | 0.070 |
Why?
|
| Leukopenia | 1 | 2008 | 212 | 0.070 |
Why?
|
| Disulfides | 1 | 2009 | 466 | 0.070 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2008 | 144 | 0.070 |
Why?
|
| Cytoskeleton | 1 | 2012 | 1167 | 0.070 |
Why?
|
| Half-Life | 1 | 2008 | 652 | 0.070 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2010 | 423 | 0.070 |
Why?
|
| Blood Pressure | 2 | 2015 | 8523 | 0.070 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2007 | 350 | 0.070 |
Why?
|
| Lipoproteins, LDL | 1 | 2010 | 641 | 0.070 |
Why?
|
| Students, Medical | 1 | 2020 | 1926 | 0.070 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 1188 | 0.070 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 3870 | 0.070 |
Why?
|
| Protein Kinases | 2 | 2005 | 1612 | 0.070 |
Why?
|
| Coronary Disease | 2 | 2010 | 5993 | 0.070 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 617 | 0.070 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2008 | 414 | 0.070 |
Why?
|
| Phosphates | 2 | 2002 | 771 | 0.070 |
Why?
|
| Embolism | 1 | 1989 | 408 | 0.070 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2007 | 489 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2008 | 484 | 0.060 |
Why?
|
| Apoptosis | 2 | 2019 | 9497 | 0.060 |
Why?
|
| Stress, Mechanical | 2 | 2008 | 1666 | 0.060 |
Why?
|
| Male | 22 | 2019 | 359413 | 0.060 |
Why?
|
| Cardiology | 1 | 2016 | 1723 | 0.060 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2009 | 854 | 0.060 |
Why?
|
| Virus Replication | 1 | 2013 | 2431 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2000 | 12968 | 0.060 |
Why?
|
| Biomedical Research | 2 | 2020 | 3421 | 0.060 |
Why?
|
| DNA | 6 | 1993 | 7236 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 4 | 2015 | 22025 | 0.060 |
Why?
|
| Acetylation | 1 | 2007 | 1062 | 0.060 |
Why?
|
| Yohimbine | 3 | 1992 | 62 | 0.060 |
Why?
|
| Benzimidazoles | 1 | 2009 | 858 | 0.060 |
Why?
|
| Arteries | 1 | 2009 | 1126 | 0.060 |
Why?
|
| Prostaglandins E | 2 | 1982 | 169 | 0.060 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 508 | 0.060 |
Why?
|
| Cardiolipins | 1 | 2023 | 81 | 0.060 |
Why?
|
| Infant, Newborn | 1 | 2024 | 26168 | 0.060 |
Why?
|
| Guanosine Triphosphate | 3 | 1982 | 316 | 0.060 |
Why?
|
| Receptors, Drug | 1 | 1983 | 157 | 0.060 |
Why?
|
| Phosphopeptides | 2 | 1996 | 241 | 0.050 |
Why?
|
| Marine Toxins | 1 | 2002 | 24 | 0.050 |
Why?
|
| Okadaic Acid | 1 | 2002 | 67 | 0.050 |
Why?
|
| Membrane Microdomains | 1 | 2004 | 206 | 0.050 |
Why?
|
| Blotting, Western | 4 | 2015 | 5039 | 0.050 |
Why?
|
| Splanchnic Circulation | 1 | 2003 | 110 | 0.050 |
Why?
|
| Calcium Channels | 2 | 1998 | 619 | 0.050 |
Why?
|
| Hypercholesterolemia | 1 | 2010 | 1155 | 0.050 |
Why?
|
| Organ Preservation Solutions | 1 | 2003 | 100 | 0.050 |
Why?
|
| Protein Transport | 2 | 2016 | 1966 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 1760 | 0.050 |
Why?
|
| CHO Cells | 2 | 1996 | 1389 | 0.050 |
Why?
|
| Models, Animal | 1 | 2009 | 2117 | 0.050 |
Why?
|
| Cricetinae | 3 | 1996 | 2427 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
| Caveolin 3 | 2 | 1998 | 24 | 0.050 |
Why?
|
| Tritium | 3 | 1996 | 707 | 0.050 |
Why?
|
| Catalysis | 1 | 2004 | 775 | 0.050 |
Why?
|
| Threonine | 1 | 2002 | 272 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2002 | 77 | 0.050 |
Why?
|
| Mitochondria | 2 | 2014 | 3598 | 0.050 |
Why?
|
| Albumins | 1 | 2004 | 577 | 0.050 |
Why?
|
| Mutagenesis | 2 | 1995 | 1234 | 0.050 |
Why?
|
| Oxazoles | 1 | 2002 | 199 | 0.050 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2003 | 266 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2016 | 4938 | 0.050 |
Why?
|
| Guanine Nucleotides | 1 | 1980 | 55 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 1997 | 3086 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2011 | 1992 | 0.050 |
Why?
|
| GTP Phosphohydrolases | 1 | 2004 | 516 | 0.050 |
Why?
|
| Cystatins | 1 | 2000 | 55 | 0.050 |
Why?
|
| Luminescence | 1 | 2001 | 133 | 0.050 |
Why?
|
| Protein Phosphatase 2 | 1 | 2002 | 236 | 0.050 |
Why?
|
| Regeneration | 1 | 2010 | 1506 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2008 | 1992 | 0.050 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2000 | 299 | 0.050 |
Why?
|
| Muscarinic Agonists | 2 | 1998 | 91 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2004 | 836 | 0.040 |
Why?
|
| Citrulline | 3 | 1995 | 106 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 1890 | 0.040 |
Why?
|
| Sequence Alignment | 3 | 1998 | 2178 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2008 | 1902 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2008 | 1174 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2000 | 203 | 0.040 |
Why?
|
| Capillaries | 1 | 2003 | 745 | 0.040 |
Why?
|
| Superoxides | 1 | 2001 | 387 | 0.040 |
Why?
|
| Nitrates | 1 | 2001 | 264 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2020 | 5867 | 0.040 |
Why?
|
| Naphthalenes | 1 | 2000 | 198 | 0.040 |
Why?
|
| Pain | 1 | 1995 | 5066 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 2895 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2011 | 3011 | 0.040 |
Why?
|
| Epitopes | 2 | 1996 | 2506 | 0.040 |
Why?
|
| Depression, Chemical | 1 | 1998 | 185 | 0.040 |
Why?
|
| Neurons | 2 | 2015 | 9416 | 0.040 |
Why?
|
| Cholinergic Agonists | 1 | 1998 | 75 | 0.040 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2001 | 504 | 0.040 |
Why?
|
| Glycosylation | 1 | 2001 | 1097 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2023 | 532 | 0.040 |
Why?
|
| Anemia | 1 | 2008 | 1511 | 0.040 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 1996 | 283 | 0.040 |
Why?
|
| Intracellular Space | 1 | 2019 | 197 | 0.040 |
Why?
|
| Enzyme Induction | 2 | 1996 | 452 | 0.040 |
Why?
|
| Calcimycin | 1 | 1998 | 213 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 426 | 0.040 |
Why?
|
| Thioredoxins | 1 | 2019 | 201 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 2016 | 2104 | 0.040 |
Why?
|
| Flavonoids | 1 | 2000 | 444 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2003 | 8157 | 0.040 |
Why?
|
| Palmitates | 1 | 1997 | 70 | 0.040 |
Why?
|
| RNA Interference | 1 | 2005 | 2846 | 0.030 |
Why?
|
| Immunosorbent Techniques | 1 | 1996 | 176 | 0.030 |
Why?
|
| Peptides | 2 | 2003 | 4358 | 0.030 |
Why?
|
| Cysteine | 2 | 2005 | 897 | 0.030 |
Why?
|
| omega-N-Methylarginine | 2 | 1993 | 108 | 0.030 |
Why?
|
| Dystrophin | 1 | 1997 | 284 | 0.030 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1996 | 71 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 2 | 2016 | 1066 | 0.030 |
Why?
|
| Actin-Related Protein 3 | 1 | 2016 | 48 | 0.030 |
Why?
|
| Sheep | 2 | 1996 | 1441 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 1997 | 426 | 0.030 |
Why?
|
| Hybrid Cells | 2 | 1994 | 422 | 0.030 |
Why?
|
| Sequence Tagged Sites | 1 | 1995 | 94 | 0.030 |
Why?
|
| Casein Kinase I | 1 | 2016 | 46 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1996 | 317 | 0.030 |
Why?
|
| Organisms, Genetically Modified | 1 | 2015 | 63 | 0.030 |
Why?
|
| Chondrocytes | 1 | 2021 | 791 | 0.030 |
Why?
|
| Angiopoietins | 1 | 2016 | 85 | 0.030 |
Why?
|
| Mutation | 4 | 2007 | 29950 | 0.030 |
Why?
|
| Methods | 1 | 1996 | 1075 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 1996 | 1792 | 0.030 |
Why?
|
| Leukodystrophy, Metachromatic | 1 | 2015 | 44 | 0.030 |
Why?
|
| Cell-Free System | 1 | 1996 | 341 | 0.030 |
Why?
|
| Sodium | 1 | 1980 | 1601 | 0.030 |
Why?
|
| Sodium Hypochlorite | 1 | 2015 | 31 | 0.030 |
Why?
|
| Research Personnel | 1 | 2020 | 584 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1995 | 852 | 0.030 |
Why?
|
| Triethylenemelamine | 1 | 1974 | 1 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2013 | 10434 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2000 | 1437 | 0.030 |
Why?
|
| Brain | 4 | 2006 | 26912 | 0.030 |
Why?
|
| RNA, Transfer, Ser | 1 | 2014 | 7 | 0.030 |
Why?
|
| Aging | 2 | 2010 | 8641 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2015 | 613 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 3601 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2004 | 2861 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 1998 | 924 | 0.030 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2016 | 251 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2014 | 12100 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2015 | 618 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1746 | 0.030 |
Why?
|
| Stomach | 1 | 1998 | 695 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 1995 | 4357 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2007 | 3127 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 1433 | 0.030 |
Why?
|
| Peptide Fragments | 2 | 2016 | 5120 | 0.030 |
Why?
|
| Ion Channel Gating | 1 | 1995 | 436 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2019 | 3105 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2016 | 865 | 0.030 |
Why?
|
| Internal Medicine | 1 | 2020 | 1045 | 0.030 |
Why?
|
| S-Adenosylmethionine | 1 | 2014 | 213 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 1994 | 4625 | 0.030 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1996 | 560 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 465 | 0.030 |
Why?
|
| Fluorescence | 1 | 2015 | 750 | 0.030 |
Why?
|
| Radioligand Assay | 3 | 1997 | 366 | 0.030 |
Why?
|
| Endothelins | 1 | 1992 | 127 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 9590 | 0.030 |
Why?
|
| Selenoproteins | 1 | 2014 | 214 | 0.030 |
Why?
|
| Rodentia | 1 | 1994 | 260 | 0.030 |
Why?
|
| Cholesterol | 2 | 2013 | 2925 | 0.030 |
Why?
|
| Intestine, Small | 1 | 1998 | 1207 | 0.030 |
Why?
|
| Adult | 4 | 2024 | 219847 | 0.030 |
Why?
|
| Binding, Competitive | 5 | 1992 | 1143 | 0.020 |
Why?
|
| Research Design | 1 | 2008 | 6181 | 0.020 |
Why?
|
| Oxyhemoglobins | 1 | 1993 | 212 | 0.020 |
Why?
|
| Hindlimb | 1 | 2014 | 510 | 0.020 |
Why?
|
| Estradiol | 1 | 1999 | 1932 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 1996 | 1064 | 0.020 |
Why?
|
| Platelet Aggregation | 2 | 1992 | 805 | 0.020 |
Why?
|
| Human Growth Hormone | 1 | 1996 | 638 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2016 | 829 | 0.020 |
Why?
|
| Faculty, Medical | 1 | 2020 | 1192 | 0.020 |
Why?
|
| Mitogens | 1 | 1991 | 230 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2023 | 3613 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1992 | 778 | 0.020 |
Why?
|
| Methylation | 1 | 2014 | 1080 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 1056 | 0.020 |
Why?
|
| Sequence Analysis | 1 | 1992 | 240 | 0.020 |
Why?
|
| Selenium | 1 | 2014 | 416 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2016 | 1201 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 9196 | 0.020 |
Why?
|
| Hypertrophy | 1 | 1992 | 555 | 0.020 |
Why?
|
| Lung | 1 | 2009 | 9989 | 0.020 |
Why?
|
| Homocysteine | 1 | 2014 | 640 | 0.020 |
Why?
|
| Liposomes | 1 | 1994 | 776 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 1993 | 410 | 0.020 |
Why?
|
| Papio | 1 | 1992 | 661 | 0.020 |
Why?
|
| Bronchi | 1 | 1994 | 848 | 0.020 |
Why?
|
| Polymers | 1 | 1998 | 1620 | 0.020 |
Why?
|
| Cell Death | 1 | 2015 | 1670 | 0.020 |
Why?
|
| Anilides | 1 | 2013 | 409 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 1993 | 553 | 0.020 |
Why?
|
| Microcirculation | 1 | 1995 | 1279 | 0.020 |
Why?
|
| Neuroglia | 1 | 2015 | 944 | 0.020 |
Why?
|
| Atropine | 2 | 2001 | 245 | 0.020 |
Why?
|
| Gene Library | 1 | 1992 | 1060 | 0.020 |
Why?
|
| Thrombophlebitis | 1 | 1989 | 289 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4573 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1992 | 2262 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 4168 | 0.020 |
Why?
|
| Drosophila | 1 | 2015 | 1492 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1994 | 2500 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1974 | 1767 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 1447 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2014 | 3096 | 0.020 |
Why?
|
| Body Composition | 1 | 1996 | 2418 | 0.020 |
Why?
|
| Forecasting | 1 | 2016 | 2931 | 0.020 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 1986 | 66 | 0.020 |
Why?
|
| Rabbits | 3 | 1998 | 4773 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 1120 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 1083 | 0.020 |
Why?
|
| Macrophages | 3 | 2005 | 5745 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1974 | 2612 | 0.020 |
Why?
|
| Lipopolysaccharides | 4 | 1995 | 2214 | 0.020 |
Why?
|
| Alprostadil | 2 | 1982 | 86 | 0.020 |
Why?
|
| Leukocytes | 1 | 2014 | 2030 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 1993 | 850 | 0.020 |
Why?
|
| Rhodopsin | 1 | 1986 | 203 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 2296 | 0.020 |
Why?
|
| Chromogenic Compounds | 1 | 2005 | 31 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2008 | 465 | 0.020 |
Why?
|
| Avidin | 1 | 2005 | 42 | 0.020 |
Why?
|
| S-Nitrosothiols | 1 | 2005 | 34 | 0.020 |
Why?
|
| Horseradish Peroxidase | 1 | 2005 | 166 | 0.020 |
Why?
|
| Resorcinols | 1 | 2005 | 41 | 0.020 |
Why?
|
| Dihydroergotoxine | 2 | 1984 | 21 | 0.020 |
Why?
|
| Alprenolol | 2 | 1982 | 8 | 0.020 |
Why?
|
| DNA Repair | 1 | 1974 | 2039 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2007 | 576 | 0.020 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 493 | 0.020 |
Why?
|
| Biotinylation | 1 | 2005 | 184 | 0.020 |
Why?
|
| Placenta | 1 | 1994 | 1701 | 0.020 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 11902 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 16543 | 0.010 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2016 | 1520 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2005 | 202 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 1995 | 11064 | 0.010 |
Why?
|
| Inflammation | 1 | 2004 | 10757 | 0.010 |
Why?
|
| Cytokines | 2 | 1996 | 7345 | 0.010 |
Why?
|
| Affinity Labels | 1 | 1983 | 107 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2007 | 1490 | 0.010 |
Why?
|
| Bone Density | 1 | 1996 | 3528 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 2004 | 426 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2003 | 201 | 0.010 |
Why?
|
| Patient Care Team | 1 | 1995 | 2510 | 0.010 |
Why?
|
| Erythrocytes | 2 | 1984 | 2415 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 2804 | 0.010 |
Why?
|
| Heme | 1 | 2005 | 313 | 0.010 |
Why?
|
| Erythrocyte Membrane | 2 | 1982 | 439 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2015 | 4223 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1983 | 534 | 0.010 |
Why?
|
| Coronary Artery Bypass | 2 | 2003 | 2273 | 0.010 |
Why?
|
| Infant | 2 | 2015 | 36030 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2004 | 568 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 565 | 0.010 |
Why?
|
| Sympatholytics | 1 | 2001 | 82 | 0.010 |
Why?
|
| E-Selectin | 1 | 2004 | 576 | 0.010 |
Why?
|
| Female | 6 | 2015 | 391011 | 0.010 |
Why?
|
| Firefly Luciferin | 1 | 2001 | 7 | 0.010 |
Why?
|
| Cell Survival | 2 | 2003 | 5796 | 0.010 |
Why?
|
| Digitonin | 1 | 1981 | 26 | 0.010 |
Why?
|
| NADPH Dehydrogenase | 1 | 2001 | 44 | 0.010 |
Why?
|
| Octopamine | 1 | 2001 | 43 | 0.010 |
Why?
|
| Spin Trapping | 1 | 2001 | 4 | 0.010 |
Why?
|
| Parasympatholytics | 1 | 2001 | 89 | 0.010 |
Why?
|
| Cyclic N-Oxides | 1 | 2001 | 73 | 0.010 |
Why?
|
| Glucose | 1 | 2013 | 4361 | 0.010 |
Why?
|
| Pituitary Neoplasms | 1 | 1990 | 1313 | 0.010 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2004 | 503 | 0.010 |
Why?
|
| Naphthoquinones | 1 | 2001 | 60 | 0.010 |
Why?
|
| Nitric Oxide Donors | 1 | 2001 | 125 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2001 | 2255 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 1992 | 2628 | 0.010 |
Why?
|
| Triglycerides | 1 | 2008 | 2476 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 835 | 0.010 |
Why?
|
| Zinc | 1 | 2005 | 690 | 0.010 |
Why?
|
| Peroxisomes | 1 | 2001 | 68 | 0.010 |
Why?
|
| Digoxin | 1 | 2001 | 247 | 0.010 |
Why?
|
| Sexual Behavior, Animal | 1 | 2001 | 118 | 0.010 |
Why?
|
| NADP | 1 | 2001 | 223 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 1992 | 2567 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2004 | 1128 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 2001 | 211 | 0.010 |
Why?
|
| Ouabain | 1 | 2000 | 247 | 0.010 |
Why?
|
| Mental Status Schedule | 1 | 2000 | 314 | 0.010 |
Why?
|
| Propranolol | 1 | 2001 | 489 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8621 | 0.010 |
Why?
|
| Benzoates | 1 | 2001 | 212 | 0.010 |
Why?
|
| Luciferases | 1 | 2001 | 716 | 0.010 |
Why?
|
| Gene Expression | 1 | 1992 | 7592 | 0.010 |
Why?
|
| Blood Glucose | 2 | 2008 | 6375 | 0.010 |
Why?
|
| Cystatin C | 1 | 2000 | 270 | 0.010 |
Why?
|
| Adipose Tissue | 2 | 2008 | 3293 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2000 | 8551 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 2000 | 264 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 2 | 1991 | 154 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 1984 | 931 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2001 | 594 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 2056 | 0.010 |
Why?
|
| Centrifugation, Isopycnic | 1 | 1997 | 8 | 0.010 |
Why?
|
| Quinuclidinyl Benzilate | 1 | 1997 | 19 | 0.010 |
Why?
|
| Receptor, Muscarinic M2 | 1 | 1997 | 15 | 0.010 |
Why?
|
| Molecular Biology | 1 | 2001 | 581 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2000 | 1265 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 2000 | 546 | 0.010 |
Why?
|
| Risk Factors | 2 | 2016 | 74269 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 1991 | 3870 | 0.010 |
Why?
|
| Muscarinic Antagonists | 1 | 1997 | 138 | 0.010 |
Why?
|
| Genotype | 2 | 2001 | 12959 | 0.010 |
Why?
|
| Jejunum | 1 | 1998 | 472 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2001 | 974 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 2001 | 1016 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2001 | 2509 | 0.010 |
Why?
|
| Homozygote | 1 | 2000 | 1786 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3774 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2004 | 2486 | 0.010 |
Why?
|
| Prognosis | 1 | 2016 | 29636 | 0.010 |
Why?
|
| Observer Variation | 1 | 2001 | 2596 | 0.010 |
Why?
|
| Norepinephrine | 2 | 1992 | 900 | 0.010 |
Why?
|
| Imidazoles | 1 | 2001 | 1178 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 1998 | 666 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2001 | 1840 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2001 | 1791 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 1995 | 315 | 0.010 |
Why?
|
| Quality of Life | 2 | 1996 | 13300 | 0.010 |
Why?
|
| Thymidine | 1 | 1974 | 299 | 0.010 |
Why?
|
| Aged | 3 | 2021 | 168995 | 0.010 |
Why?
|
| Haplotypes | 1 | 2000 | 2764 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 1699 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 2755 | 0.010 |
Why?
|
| Cell Communication | 1 | 2001 | 1642 | 0.010 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 1995 | 298 | 0.010 |
Why?
|
| Age of Onset | 1 | 2000 | 3302 | 0.010 |
Why?
|
| Autoradiography | 1 | 1974 | 730 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1996 | 1705 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2015 | 42034 | 0.010 |
Why?
|
| Obesity | 1 | 2015 | 12915 | 0.010 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1991 | 87 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 1997 | 1152 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1993 | 522 | 0.010 |
Why?
|
| Glomerular Mesangium | 1 | 1991 | 98 | 0.010 |
Why?
|
| Motor Activity | 1 | 2001 | 2687 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1998 | 1614 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2001 | 5873 | 0.010 |
Why?
|
| Species Specificity | 1 | 1994 | 2413 | 0.010 |
Why?
|
| Colon | 1 | 1998 | 1788 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 3822 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2000 | 4286 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1991 | 1085 | 0.010 |
Why?
|
| Epithelium | 1 | 1994 | 1605 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14656 | 0.010 |
Why?
|
| Immune Sera | 1 | 1990 | 613 | 0.010 |
Why?
|
| Oxygen | 1 | 2001 | 4189 | 0.010 |
Why?
|
| Renal Artery | 1 | 1991 | 368 | 0.010 |
Why?
|
| Alleles | 1 | 2000 | 6900 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1991 | 617 | 0.010 |
Why?
|
| Antibodies | 1 | 1997 | 2424 | 0.010 |
Why?
|
| Thrombin | 1 | 1991 | 593 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 58673 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1996 | 1920 | 0.010 |
Why?
|
| Risk | 1 | 2000 | 9629 | 0.000 |
Why?
|
| Odds Ratio | 1 | 2000 | 9712 | 0.000 |
Why?
|
| Electrocardiography | 1 | 2001 | 6413 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1987 | 553 | 0.000 |
Why?
|
| Transforming Growth Factor beta | 1 | 1995 | 1956 | 0.000 |
Why?
|
| Child | 1 | 2015 | 79758 | 0.000 |
Why?
|
| Adolescent | 1 | 2015 | 87747 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 6131 | 0.000 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1987 | 430 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1987 | 1304 | 0.000 |
Why?
|
| Bone and Bones | 1 | 1996 | 2560 | 0.000 |
Why?
|
| Logistic Models | 1 | 2000 | 13311 | 0.000 |
Why?
|
| Lipids | 1 | 1996 | 3336 | 0.000 |
Why?
|
| Adenylate Cyclase Toxin | 1 | 1984 | 25 | 0.000 |
Why?
|
| Middle Aged | 3 | 2000 | 220175 | 0.000 |
Why?
|
| Turkeys | 1 | 1984 | 45 | 0.000 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1984 | 73 | 0.000 |
Why?
|
| Bucladesine | 1 | 1984 | 118 | 0.000 |
Why?
|
| Mesocricetus | 1 | 1984 | 252 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1974 | 2918 | 0.000 |
Why?
|
| Fluorides | 1 | 1984 | 134 | 0.000 |
Why?
|
| Educational Status | 1 | 1991 | 2512 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1991 | 2937 | 0.000 |
Why?
|
| Anura | 1 | 1982 | 80 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2000 | 22041 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1991 | 6226 | 0.000 |
Why?
|
| Phentolamine | 1 | 1982 | 102 | 0.000 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1984 | 619 | 0.000 |
Why?
|
| Prazosin | 1 | 1982 | 95 | 0.000 |
Why?
|
| Orthopedics | 1 | 1991 | 891 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 1996 | 4923 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1992 | 3764 | 0.000 |
Why?
|
| Dihydroalprenolol | 1 | 1981 | 8 | 0.000 |
Why?
|
| Genetic Markers | 1 | 1987 | 2608 | 0.000 |
Why?
|
| Ranidae | 1 | 1981 | 32 | 0.000 |
Why?
|
| Phosphorylases | 1 | 1980 | 17 | 0.000 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1980 | 174 | 0.000 |
Why?
|
| Exercise | 1 | 1996 | 5783 | 0.000 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1980 | 178 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2000 | 17766 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1991 | 9283 | 0.000 |
Why?
|
| United States | 1 | 2001 | 72363 | 0.000 |
Why?
|